The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol. 1984

T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould

Pimozide and haloperidol were found to be equally effective in the treatment of acute schizophrenia in a double-blind clinical trial involving 22 patients. Drug plasma levels measured by radioimmunoassay (RIA) did not correlate with clinical response following either drug. Nor was there any correlation between clinical response and the dopamine receptor blocking activity of either drug as measured by radio receptor assay (RRA). Following pimozide plasma prolactin (PRL) levels correlated with clinical change, although the time courses of response of PRL and clinical response were dissimilar. There was no correlation between PRL and clinical response to haloperidol. RRA and RIA values correlated highly following pimozide but not haloperidol. Our findings lead us to conclude that the RRA technique reflects the plasma level of a drug rather than its central dopamine blocking activity. We also consider that the clinical response to antipsychotic drugs in schizophrenia may be less directly linked to dopamine receptor blockade than has previously been supposed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
March 1981, The American journal of psychiatry,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
November 1979, Pharmacology, biochemistry, and behavior,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
August 2001, Psychiatry research,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
January 1974, Acta psychiatrica Scandinavica. Supplementum,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
May 1980, Research communications in chemical pathology and pharmacology,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
December 1999, Psychiatry research,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
December 2001, The British journal of psychiatry : the journal of mental science,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
June 1994, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
January 1981, Journal of clinical pharmacology,
T Silverstone, and J Cookson, and R Ball, and C N Chin, and D Jacobs, and S Lader, and S Gould
January 1999, Psychopharmacology,
Copied contents to your clipboard!